Clinical Trial Update: Comparison of Atomoxetine Plus Either Comparator or Placebo in Children With ADHD Who Haven't Responded to Stimulant Therapy [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating atomoxetine in children with ADHD who did not respond to stimulant therapy, comparing atomoxetine plus a comparator to …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Atomoxetine (Atomoxetine)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Attention Deficit Hyperactivity Disorder | Phase 3 | Status: COMPLETED